A Randomized Controlled Clinical Trial to Evaluate Safety and Effectiveness of CAF + Mucograft® Compared to CAF Alone in Patients With Gingival Recessions
MCT-Recession
1 other identifier
interventional
45
1 country
1
Brief Summary
The purpose of this multi-center study is to determine the efficacy and safety of Mucograft® in combination with the coronally advanced flap (CAF) for the treatment of gingival recessions. It is assumed that the CAF combined with Mucograft® will result in improved outcome in terms percentage of root coverage and soft tissue thickness in comparison to CAF alone (control).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
May 14, 2009
CompletedFirst Posted
Study publicly available on registry
May 15, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedFebruary 8, 2019
February 1, 2012
2.3 years
May 14, 2009
February 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
percentage of root coverage
6 month
Secondary Outcomes (1)
gingival thickness
6 month
Study Arms (2)
Mucograft + CAF
EXPERIMENTALMucograft in combination with coronally advanced flap (CAF)
CAF
EXPERIMENTALCoronally advanced flap (CAF) alone
Interventions
Eligibility Criteria
You may qualify if:
- The patient (male or female) must be 18 years or older
- The patient must be a candidate for bilateral root coverage procedure
- Recession defects are Miller Class I-II and do not vary more than 2 mm.
- At least one mm keratinized tissue is present.
- Patient shows sufficient plaque control (FMPS \< 20%).
- If patient is of child-bearing potential, the patient confirms not to be pregnant and agrees to take contraception for at least 6 months after surgery.
- The patient is able to comply with the study-related procedures such as exercising good oral hygiene and attending all follow-up procedures
- The patient is able to fully understand the nature of the proposed surgery and is able to provide a signed informed consent.
You may not qualify if:
- Patient is a heavy smoker (\> 10 cigarettes per day)
- Patient is an insulin dependent diabetic
- General contraindications for dental and/or surgical treatment are present.
- The patient has a history of malignancy, radiotherapy, or chemotherapy for malignancy within the past five years.
- The patient is pregnant or nursing
- The patient is taking medications or having treatments which have an effect on mucosal healing in general (e.g. steroids, large doses of anti-inflammatory drugs).
- The patient has a disease, which affects connective tissue metabolism (e.g. collagenases).
- The patient is allergic to collagen.
- Patients have participated in a clinical trial within the last six months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prof. Mariano Sanz
Madrid, 2804, Spain
Related Publications (1)
Jepsen K, Stefanini M, Sanz M, Zucchelli G, Jepsen S. Long-Term Stability of Root Coverage by Coronally Advanced Flap Procedures. J Periodontol. 2017 Jul;88(7):626-633. doi: 10.1902/jop.2017.160767. Epub 2017 Mar 17.
PMID: 28304210DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mariano Sanz, Prof.
Department of Periodontology, University Complutense Madrid, Spain
- PRINCIPAL INVESTIGATOR
Soren Jepsen, Prof.
Department of Periodontology, University of Bonn, Germany
- PRINCIPAL INVESTIGATOR
Jan Wennström, Prof.
Department of Periodontology, University of Gothenburg, Sweden
- PRINCIPAL INVESTIGATOR
Giovanni Zucchelli, Prof.
Department of Periodontology, University of Bologna, Italy
- STUDY DIRECTOR
Lorenz Uebersax, Dr.
Geistlich Pharma AG, Wolhusen, Switzerland
- PRINCIPAL INVESTIGATOR
Bernd Heinz, Dr
Private practice Hamburg, Germany
- PRINCIPAL INVESTIGATOR
Massimo DeSanctis, Prof.
Private Practice Firenze
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2009
First Posted
May 15, 2009
Study Start
March 1, 2009
Primary Completion
July 1, 2011
Study Completion
January 1, 2012
Last Updated
February 8, 2019
Record last verified: 2012-02